Telix Pharmaceuticals Ltd. (AU:TLX) has released an update.
Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Telix Pharmaceuticals Limited has announced the cessation of various securities, including share rights, share appreciation rights, and options, due to the non-fulfillment of underlying conditions. The affected securities had various lapse dates in 2024, with a total number of 681,762 securities ceasing. Investors are alerted to these changes, which may influence the company’s stock performance.
For further insights into AU:TLX stock, check out TipRanks’ Stock Analysis page.
